Browsing by Subject "attenuated influenza vaccine"
Now showing items 1-1 of 1
-
Modified vaccinia virus ankara preferentially targets antigen presenting cells in vitro, ex vivo and in vivo
(Springer Nature, 2017-08-17)Modified Vaccinia virus Ankara (MVA) is a promising vaccine vector with an excellent safety profile. However, despite extensive pre-clinical and clinical testing, surprisingly little is known about the cellular tropism of ...